CRIMALDDI: platform technologies and novel anti-malarial drug targets

被引：0
|
作者：
Henri Vial
Donatella Taramelli
Ian C Boulton
Steve A Ward
Christian Doerig
Kelly Chibale
机构：
[1] Université Montpellier 2,Centre National de la Recherche Scientifique, UMR 5235
[2] Università di Milano,Dipartmento di Scienze Farmacologiche e Biomolecolari
[3] TropMed Pharma Consulting Ltd,Department of Microbiology
[4] Liverpool School of Tropical Medicine,Department of Chemistry
[5] School of Biomedical Sciences,undefined
[6] Monash University,undefined
[7] University of Cape Town,undefined
来源：
Malaria Journal | / 12卷
关键词：
CRIMALDDI; Malaria; Drug discovery; Research agenda; Novel targets; Enabling technologies; Prioritization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The Coordination, Rationalization, and Integration of antiMALarial drug Discovery & Development Initiatives (CRIMALDDI) Consortium, funded by the EU Framework Seven Programme, has attempted, through a series of interactive and facilitated workshops, to develop priorities for research to expedite the discovery of new anti-malarials. This paper outlines the recommendations for the development of enabling technologies and the identification of novel targets.
引用
收藏
相关论文
共 50 条
  • [1] CRIMALDDI: platform technologies and novel anti-malarial drug targets
    Vial, Henri
    Taramelli, Donatella
    Boulton, Ian C.
    Ward, Steve A.
    Doerig, Christian
    Chibale, Kelly
    MALARIA JOURNAL, 2013, 12
  • [2] CRIMALDDI: a prioritized research agenda to expedite the discovery of new anti-malarial drugs
    Ward, Steve A.
    Boulton, Ian C.
    MALARIA JOURNAL, 2013, 12
  • [3] CRIMALDDI: a prioritized research agenda to expedite the discovery of new anti-malarial drugs
    Steve A Ward
    Ian C Boulton
    Malaria Journal, 12
  • [4] CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives
    Ian C Boulton
    Solomon Nwaka
    Ian Bathurst
    Michael Lanzer
    Donatella Taramelli
    Henri Vial
    Christian Doerig
    Kelly Chibale
    Steve A Ward
    Malaria Journal, 9
  • [5] Anti-malarial drug formulations and novel delivery systems: A review
    Murambiwa, P.
    Masola, B.
    Govender, T.
    Mukaratirwa, S.
    Musabayane, C. T.
    ACTA TROPICA, 2011, 118 (02) : 71 - 79
  • [6] Fragment Screening in the Development of a Novel Anti-Malarial
    Du, Xiaochen
    Zhang, Ran
    Groves, Matthew R.
    CRYSTALS, 2023, 13 (12)
  • [7] Plasmodial sugar transporters as anti-malarial drug targets and comparisons with other protozoa
    Ksenija Slavic
    Sanjeev Krishna
    Elvira T Derbyshire
    Henry M Staines
    Malaria Journal, 10
  • [8] Novel anti-malarial combinations and their toxicity
    Angus, Brian
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (03) : 299 - 316
  • [9] Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate
    Matthews, Holly
    Usman-Idris, Maryam
    Khan, Farid
    Read, Martin
    Nirmalan, Niroshini
    MALARIA JOURNAL, 2013, 12
  • [10] Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
    Monatrakul, Preeyaporn
    Mungthin, Mathirut
    Dondorp, Arjen M.
    Krudsood, Srivicha
    Udomsangpetch, Rachanee
    Wilairatana, Polrat
    White, Nicholas J.
    Chotivanich, Kesinee
    MALARIA JOURNAL, 2010, 9
12345